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Background: Whole genome sequencing of viruses and bacteriophages is often hindered because of the need for
large quantities of genomic material. A method is described that combines single plaque sequencing with an
optimization of Sequence Independent Single Primer Amplification (SISPA). This method can be used for de novo
whole genome next-generation sequencing of any cultivable virus without the need for large-scale production of
viral stocks or viral purification using centrifugal techniques.
Methods: A single viral plaque of a variant of the 2009 pandemic H1N1 human Influenza A virus was isolated and
amplified using the optimized SISPA protocol. The sensitivity of the SISPA protocol presented here was tested with
bacteriophage F_HA0480sp/Pa1651 DNA. The amplified products were sequenced with 454 and Illumina HiSeq
platforms. Mapping and de novo assemblies were performed to analyze the quality of data produced from this
optimized method.
Results: Analysis of the sequence data demonstrated that from a single viral plaque of Influenza A, a mapping
assembly with 3590-fold average coverage representing 100% of the genome could be produced. The de novo
assembled data produced contigs with 30-fold average sequence coverage, representing 96.5% of the genome.
Using only 10 pg of starting DNA from bacteriophage F_HA0480sp/Pa1651 in the SISPA protocol resulted in
sequencing data that gave a mapping assembly with 3488-fold average sequence coverage, representing 99.9% of
the reference and a de novo assembly with 45-fold average sequence coverage, representing 98.1% of the genome.
Conclusions: The optimized SISPA protocol presented here produces amplified product that when sequenced will
give high quality data that can be used for de novo assembly. The protocol requires only a single viral plaque or as
little as 10 pg of DNA template, which will facilitate rapid identification of viruses during an outbreak and viruses
that are difficult to propagate.
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During a viral outbreak, it is highly desirable to rapidly
determine the identity of the causative agent through
whole genome sequencing. Genome sequencing of novel
viruses and bacteriophages (phages) is often difficult and
time consuming due to the need to grow large-scale, high
titer lysates in order to obtain a sufficient quantity of viral
nucleic acids for whole genome sequencing. Though
metagenomic techniques have been utilized to sequence* Correspondence: dfouts@jcvi.org
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reproduction in any medium, provided the oruncultured viruses and phages from the environment [1,2]
and the human gut [3-5], the genome sequence of any
single virus in these samples is typically incomplete.
These techniques also require nanogram or microgram
quantities of nucleic acid for library construction and
require highly purified viral particles to prevent sequencing
of contaminating host genomes. Furthermore, it is difficult
to know the host of viruses taken from a metagenomic
study unless the virus is cultivated on a suitable host.
Methods have been described for the direct Sanger
sequencing of λ and M13 library clones from single
plaques [6,7], but are unsuitable for de novo whole genome
sequencing of novel viruses because they were designed toLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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phage specific oligonucleotide primers rather than
complete phage genomes primed using random primers.
The objective of this study was to optimize a method that
combines single plaque sequencing with an optimized
random-primed amplification method [8] that can be used
for de novo genome sequencing of any cultivable virus
without the need for large-scale production of viral stocks
or viral purification using ultracentrifugal techniques.
Methods
General
All enzymatic reactions were prepared with sterile water
that was deionized using a Milli-QW water purification
system. For RNA work, all reagents were made with
DEPC-treated sterile deionized water. BenzonaseW was
obtained from Sigma Chemical Company. RNases A and
T1 were obtained from Ambion. EMEM, BSA fraction V,
antibiotic-antimycotic, RNaseOUT™ and SuperScriptW III
Reverse Transcriptase (SSIIIRT) were obtained from
Invitrogen. Tosylsulfonyl phenylalanyl chloromethyl ketone
(TPCK)-treated trypsin was purchased from Worthington
Biochemical Corporation (Lakewood, NJ). BioMix™ Red
DNA polymerase was obtained from Bioline. The RNeasy
Mini and QIAquick Gel Extraction kits were purchased
from Qiagen. Polyethylene glycol (PEG) 8000 was obtained
from USB Corporation. All other enzymes and dNTPs
were obtained from New England Biolabs. All reagents
used were of molecular biology grade or higher.
Influenza virus plaque growth
To obtain a single plaque of a mouse-adapted variant
(NY1682-MAP7) of a 2009 H1N1 pandemic Influenza A
virus [9], a monolayer of MDCK cells [ATCC CCL-34]
in a six-well plate was infected with serially diluted virus
for 1 h and covered with an overlay containing 1% agarose,
1X EMEM, 0.3% BSA fraction V, 1% antibiotic-antimycotic,
and 2 μg/ml TPCK-treated trypsin. After two days of
incubation at 37°C, a single plaque was picked using a
sterile Pasteur pipette. The plug was incubated overnight in
SM buffer (0.01% gelatin, 250 mM NaCl, 8.5 mM MgSO4,
50 mM Tris–HCl, pH 7.5) to release the viral particles
from the agarose.
Nucleic acid extraction
After overnight incubation, the viral plug was filtered
through a 0.45 μm syringe filter to remove host cells. The
filtrate was treated with 125 U Benzonase, 10 U DNase I,
50 U RNase A and 200 U RNase T1 at 37°C for 1 h.
Nucleases were deactivated by bringing the concentrations
of both EDTA and EGTA up to 50 mM. Influenza viral
RNA was purified using the RNeasy Mini Kit from Qiagen
following the manufacturer’s instructions. The RNA was
eluted in 25 μl of RNase-free DEPC-treated water.Modified SISPA protocol
Bacteriophage F_HA0480sp/Pa1651 Klenow reactions
were performed in duplicate to increase the coverage of
the target genome [10]. Template DNA was added so
that 10 pg of DNA was added in a 2 μl volume, and
0.5 μl of 50% DMSO was added to aid in denaturing.
Templates were incubated at 95°C for 5 min on a thermal
cycler followed immediately with snap cooling on ice. After
cooling for 5 min, 1 μl of 100 μM barcoded random
hexamer primer FR20RV-N [8] (5′ GCC GGA GCT CTG
CAG ATA TCN NNN NN 3′) or BC081N (5′ CGA GAG
ATA CTG TAC TAG AGC GNN NNN N 3′) for Illumina
or 454 sequencing, respectively, was added to each reaction.
To allow optimal binding of the random primers, the reac-
tions were incubated with a 1°C per min ramp from 4°C to
37°C on the thermal cycler. Random-primed amplification
was achieved using 1.5 U exo- Klenow fragment, 1× NEB
Buffer 2 and 0.2 mM dNTPs in 5 μl reactions incubated at
37°C for 1 h. A second round of amplification was
performed with the addition of 2.5 U of exo- Klenow
fragment incubated at 37°C for 1 h. The Klenow reaction
was terminated by heat inactivation at 75°C for 15 min.
Influenza A virus amplification reactions were also
performed in duplicate. The RNA template was split into
two aliquots for first strand synthesis, and 2 μl of
100 μM barcoded random hexamer primer BC391N
(5′ CGT GAC TAT CTC GCG AGT ACG ANN
NNN N 3′), 1 μL of solution containing 10 mM of
each dNTP and 0.6 μL of 10% DMSO were added to
each. Final volumes were brought up to 10 μL with
DEPC-treated water and samples were incubated at
96°C for 5 min, then snap-cooled on ice. 4 μl 5× First
Strand Buffer (Invitrogen), 2 μl 0.1 M DTT, 0.2 μl
RNaseOUT (40 U/μL), 0.5 μl SSIIIRT (200 U/μl), and
3.3 μl DEPC-treated water were added to each sample.
Reverse transcription occurred on the thermal cycler at
25°C for 10 min followed by 50°C for 50 min, and finished
by incubation at 85°C for 10 min before being snap-
cooled on ice. To destroy the RNA template, the reaction
was then treated with 5 U RNase H and incubated at 37°C
for 20 min followed by heat inactivation at 85°C for
10 min. A second round of amplification was performed
with the addition of 2.5 U exo- Klenow fragment and
incubation at 37°C for 1 h followed by heat inactivation at
75°C for 15 min.
The cleanup of Klenow reactions involved removal of
primers and short fragments by diluting with 20 μl of
water and mixing with 10 μl of 30% PEG 8000 with
5 mM MgCl2 [11] to adjust the final concentration of
PEG and MgCl2 to 8.7% and 1.4 mM, respectively.
Mixtures were then incubated on ice for 15 min and
then centrifuged at 16100 × g at 4°C for 30 min. The
supernatant from each reaction was removed and pellets
were reconstituted with 20 μl of water. Single-stranded
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Exonuclease I in 1 × Exonuclease I buffer at 37°C for
30 min. Exonuclease I was then heat inactivated at
80°C for 20 min.
Amplification of double-stranded SISPA products
Duplicate Klenow reactions were pooled after cleanup.
PCR reactions contained 5 μl of cleaned Klenow product,
400 nM of barcoded primer (lacking the 3′ random
hexamer) and 25 μl of BioMix Red in a total volume of
50 μl. PCR conditions included an initial denaturation step
at 98°C for 30 s followed by 35 cycles of (98°C for
10 s, 54°C for 20 s, 72°C for 45 s). A final extension
at 72°C for 5 min completed the PCR. The completed
reactions were reduced to half of the starting volume
in a Thermo Savant DNA 120 SpeedVac and then the
entire reaction was loaded onto a 1.2% agarose gel
and stained with ethidium bromide. Smears between
300 and 850 bp in size were extracted from the agarose
gel using a QIAquick Gel Extraction Kit following the
manufacturer’s instructions. The DNA was eluted with
12.5 μl of TE buffer pre-warmed to 65°C.
454 sequencing
Viral genomes were sequenced with the 454 FLX Titanium
platform. Library construction, emulsion PCR (emPCR),
enrichment and 454 sequencing were performed by
following the vendor’s standard protocols, with some
modifications. Specifically, SISPA products were not
sheared and entered the library preparation workflow at the
standard adaptor ligation step. Quantitative PCR (qPCR)
was used to accurately estimate the number of molecules
needed for emPCR using a KAPA Biosystems Library
Quantification Kit. A BioMekW FX automation workstation
was used to “break” the emulsions after emPCR and
butanol was used to enable easier sample handling during
the breaking process. The REM e (Robotic Enrichment
Module) from Roche was used to automate the bead
enrichment process in the pipeline.
Illumina sequencing
Viral genomes were also sequenced with the Illumina
HiSeq 2000 platform. Libraries were prepared following
Illumina’s standard protocol, with a few exceptions. As
with the 454 library construction procedure, SISPA
products were not sheared and entered the library
preparation workflow at the DNA end repair step. All
cleanup steps were performed using Agencourt
AMPure XP beads. The libraries were quantitated and
quality controlled using the Agilent High Sensitivity
DNA Kit and by qPCR using a KAPA Biosystems Library
Quantification Kit. Cluster generation and sequencing
were completed utilizing Illumina’s standard protocol.Sequence preprocessing
Sequences were de novo assembled using the Newbler GS
De Novo Assembler version 2.6 (Roche Diagnostics Corp.,
Indianapolis, IN) after the following pre-processing steps:
1) removal of host contamination by mapping reads to a
contaminant reference database (see below) using the
CLC Assembly Cell’s long read reference mapper with
a minimum query length of 40% and 95% identity; 2)
k-mer normalization (i.e., read correction) followed by
exact sequence deduplication using a partial run of
ALLPATHS-LG [12]; 3) mask low complexity/highly
repetitive regions using DUST [13]; 4) dynamically
quality trim reads using CLC Assembly Cell, cutoff
QV= 18 or 2 contiguous ambiguous bases; 5) post-
trimming contaminant removal as in step 1; and 6) second-
ary barcode removal of partial SISPA adapter matches using
CutAdapt [14]. For step 1, the contaminate database for
filtering the influenza sample consisted of the human and
canine genomes. For the phage sample, the contaminate
database consisted of human genome and the genome
of Pseudomonas aeruginosa strain PAO1 [GenBank:
AE004091] (i.e., the host genome) with Phage_Finder
[15] predicted prophage regions masked out.
Sequence assembly and mapping
The resulting cleaned-up reads were assembled using
Newbler GS De Novo Assembler with minimum fragment
length of 40 to allow use of Illumina reads shortened by
adapter trimming. For de novo assemblies, read coverage
was reduced to uniform levels via cross-comparison of
read median k-mer frequencies. Sequence reads or contigs
were mapped using the high-throughput “Map Reads to
Reference” software in CLC Workbench version 5.5.1
(www.clcbio.com) using default settings. Identification of
single nucleotide polymorphisms (SNPs) in the de novo
assembled contigs was performed using the “Probabilistic
Variant Detection” software in CLC Workbench using
default settings.
Results
The lowest concentration of template required for
successful amplification using the modified SISPA
protocol was determined by testing a serial dilution of
a template phage whose complete genome sequence is
known, bacteriophage F_HA0480sp/Pa1651 [GenBank:
JN808773.1], which is 37,374 bp in length. Gel-purified
SISPA product generated from 10 pg of purified bacterio-
phage F_HA0480sp/Pa1651 genomic DNA produced a
total of 32,415 454 Titanium reads and 5,111,598 HiSeq
reads. This small amount of starting material was sufficient
to produce mapping assemblies with 3488-fold average
sequence coverage, representing 99.9% of the reference and
de novo assemblies with 45-fold average sequence coverage,
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Figure 1 Mapping and de novo assembly coverage sequencing results for the phage SISPA product from 10 pg of genomic DNA. The
black lines along the x-axis are the de novo assembled contigs mapped to the reference (light gray line across the x-axis). Coverage for the de
novo contigs is shown with dark gray bars in the graph (left y-axis). The coverage from mapping the reads to the reference is represented with a
black line (right y-axis).
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there were no SNPs observed. The number of reads used
for assembly was reduced after removing low levels of
human contamination (0.05%), Pseudomonas aeruginosa
host contaminantion (1.4%) and variable length SISPA
adapter contamination (4.0%). In comparison, the de
novo assembly result is more robust when more DNA
(30 ng) was used in SISPA reactions, which resulted
in one assembled contig used to generate the GenBank
reference (data not shown); however, the majority of the
genome sequence was obtained from as little as 10 pg of
template DNA.
In order to determine if this method is capable of
producing a complete or nearly complete de novo
assembled viral genome from a single isolated viral plaque,
a variant of the 2009 pandemic H1N1 human Influenza A
virus NY1682-MAP7 was plated and a single plaque was
subjected to the modified SISPA protocol. The gel-purified
SISPA products were sequenced with 454 Titanium and
Illumina HiSeq platforms, generating a total of 7,732
Titanium and 1,726,976 HiSeq reads. The sequencing reads
were mapped to the reference Influenza genome [GenBank:
CY054699-706] and produced a mapping assembly with
3590-fold average coverage representing 100% of the
genome. The data was also de novo assembled using the
Newbler Assembler following the removal of input reads
with high sequence identity matches to canine host cells
(11.9%), human contaminating sequences (0.7%) and readscontaining fragmented SISPA adapter sequences
(7.0%). The resulting contigs were mapped to the reference,
producing a mapping assembly with 30-fold average
sequence coverage, representing 96.5% of the genome
(Figure 2). For the segments of PB2, PA, HA, NP, and NA,
6 to 100 bases were missing at the 5′ terminus of each
segment, whereas for the segments of PB1, M and NS, the
5' terminal sequences were obtained. A SNP analysis of the
de novo assembly to the reference sequence revealed 4
SNPs, only 3 resulting in amino acid changes (PA:
Val521Ile; NA: Ile185Met; HA: Gly172Glu). However, these
SNPs were expected since an Influenza A virus population
is known to be a quasispecies, and any single virus from
that population may have different sequences compared to
the consensus sequence of that population [16]. The de
novo assembly result of terminal un-covered regions was
due to the fact that the SISPA method had relatively lower
coverage at the end of linear segments. To add sequence
coverage at the genome ends, Djikeng et al. used additional
primers specific to the genome ends when performing
SISPA [8]; however, adding these sequence-specific primers
is not feasible or necessary in this study since the purpose
was to modify the SISPA protocol so it can be used to
sequence novel viruses where the sequence is unknown.
Discussion
Before attempting to amplify viral genomes from single
isolated plaques, a whole genome amplification method
Figure 2 Mapping and de novo assembly coverage sequencing results for the flu SISPA product from a single plaque. The black lines
along the x-axis are the de novo assembled contigs mapped to the reference (light gray line across the x-axis). Coverage for the de novo contigs is shown
with dark gray bars in the graph (left y-axis). The coverage from mapping the reads to the reference is represented with a black line (right y-axis).
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amplification using the Φ29 DNA polymerase (a.k.a.
multiple displacement amplification or MDA) requires
at least 1 ng of template [17], but a single plaque of
bacteriophage λ contains ~0.1 ng of double-stranded
DNA (~ 2 × 106 particles) [18]. Another method,
Sequence Independent Single Primer Amplification
(SISPA) [8,19] has an advantage over MDA in that
branching does not occur during amplification. SISPA
is also more convenient in that both amplificationand fragmentation of the genome are done simultaneously,
whereas MDA requires separate time-consuming amplifica-
tion and fragmentation steps toward the generation of a
genomic library for sequencing. SISPA, as modified by
Djikeng et al., can routinely amplify between 0.25 and 10
ng of ssRNA and dsDNA templates, respectively [8].
The Klenow reactions of the SISPA method were
optimized through more robust removal of host
nucleic acids, altered denaturation and annealing
conditions, reduced reaction volumes and greater
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thoroughly removed by using RNase T1 and BenzonaseW
in addition to the standard RNase A and DNase I
treatment [8]. RNase T1 combined with RNase A resulted
in smaller RNA fragments after digestion than when using
RNase A alone (data not shown). BenzonaseW, a genetic-
ally engineered endonuclease that can degrade all forms of
DNA and RNA, has been shown to be more effective at
digesting DNA than DNase I alone [20]. Taking these
additional steps in decontaminating the viral sample of
host DNA and RNA allows for increased sensitivity in the
subsequent amplification process. The addition of DMSO
to the denaturation step was not previously used for
SISPA [8]; however, it has been shown to disrupt
secondary structure of DNA to achieve higher yields
in PCR [21]. DMSO can increase non-specific annealing,
which is advantageous for random amplification. A snap
cooling step after denaturing the template and a
temperature ramp for random primer binding were also
found to increase the sensitivity and amount of product
generated (data not shown). Finally, amplification reaction
volumes were optimized through volume reduction
(e.g., 5–10 μl) to allow for the template to be at a
higher concentration for specific amplification [22].
The concentration of random hexamer primers was greater
than originally used for SISPA [8]. It has been previously
shown that increasing the primer concentration in PCR
results in greater amplification [23] with the consequence
of increased non-specific priming, which again is desirable
for random amplification of template.
Despite the addition of multiple nucleases, host and
human sequences can still be present, albeit at a relatively
low level. When amplifying genomic material from very
small quantities, the smallest amount of contaminating
nucleic acids can cause problems and can be minimized
with good sterile technique. Human contaminating
sequences can enter before or during the random priming
or the library construction steps. Host genomic material
can be shielded from nuclease digestion if bound by protein
or membranes. For example, it has been known for many
years that histones protect DNA from nuclease digestion
[24]. Indeed, we saw more contamination from the canine
host genome than from the Pseudomonas host genome.
These low levels of contamination can be removed
informatically through similarity searches.
The PCR step of the SISPA protocol was also improved
by adding an additional cleanup step to the Klenow reac-
tion and optimizing PCR for products of a size range more
applicable to next-generation sequencing technologies
rather than Sanger sequencing. The Klenow products were
purified using PEG precipitation [11,25,26] prior to treat-
ment with Exonuclease I to help ensure the amplification
would contain minimal background generated from any
primers or small fragments from the Klenow reaction. Theelongation time of the PCR was decreased in order to shift
products to a shorter size range that is more suitable for
library creation for 454 and Illumina HiSeq platforms. PCR
products were also gel extracted in a lower range (300–850
bp) than previously used for SISPA (500–1000 bp) [8] for
the same reason. This purification method also resulted in
a more robust yield of PCR products with less loss
than column purification methods.
Our SISPA protocol was optimized to be able to amplify
the minute amount of nucleic acid in a single isolated viral
plaque. Starting with just a single isolated viral plaque is
advantageous for those samples that are difficult to propa-
gate in the lab and also saves time as culture scale-up and
ultracentrifugation are not required. Additionally, there is
less host contamination present in just one viral plaque
compared to a large liquid stock, allowing for cleaner
downstream analysis. The protocol was optimized using a
greater concentration of random hexamer primers than ori-
ginally used for SISPA without the need for tagged poly-dT
or conserved sequence primers [8], enabling this method to
have a more universal application. Because genomic se-
quences may exist that are complimentary to the barcode
sequence, which will result in uneven sequence coverage, it
may be necessary to use more than one barcode per sample
to compensate for any sequencing pile up. These changes
have produced a SISPA protocol that is robust enough such
that a single viral plaque can provide sequencing data that
is acceptable for mapping or de novo assembly.
Conclusions
DNA quantities of as low as 10 picograms were sufficient to
span 98% of a bacteriophage genome by de novo assembly
of 454 and Illumina HiSeq data. This procedure was used
successfully to sequence and de novo assemble a variant of
the 2009 pandemic H1N1 human Influenza A virus [9]
from a single viral plaque. The method works with 454 and
Illumina HiSeq platforms and should also work well on any
amplicon-based sequencing platform, including the third
generation PacBio or Ion Torrent sequencing technologies.
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